Boston Scientific inks $160m deal for peripheral stent maker Veniti

August 8, 2018 By Fink Densford Leave a Comment

Boston Scientific (NYSE:BSX) said today it inked a deal worth up to $160 million to acquire stent developer Veniti.

Marlborough, Mass.-based Boston Scientific said it currently owns 25% of the company and will pay $108 million in up-front cash for the remaining stake in Veniti, with an additional $52 million on the line in milestone payments dependent upon FDA approval of its Vici stent system.

The Vici is a nitinol stent system developed specifically for use in the venous anatomy, and is designed to withstand compression and maintain patency and flexibility through out a patient’s lifespan, Boston Scientific said.

Veiniti won CE Mark approval for the Vici stent in 2013 and submitted an FDA premarket approval application in June based on results from a pivotal study of the device. Currently, there are no stents specifically indicated for use in the peripheral venous system in the US, Boston Scientific said.

“This stent system was designed with the distinctive demands of the venous system in mind, and built to provide physicians with a high-quality lumen across a variety of venous anatomies and disease states. We are excited to see this stent technology become even more accessible to physicians and the patients they treat under the leadership of Boston Scientific,” Veniti prez & CEO Jeff Elkins said in a prepared statement.

Boston Scientific said it expects the acquisition to be immaterial to its EPS this year and next, and accretive after.

“With the unique benefits of this differentiated technology and the strong experience of Boston Scientific in the overall venous market, we believe the Vici stent will become an important choice for physicians who choose stents to treat patients suffering from venous disease. Along with our leading AngioJet thrombectomy platform and venous product pipeline, we look forward to meeting the needs of physicians treating both chronic and acute venous disease,” Boston Scientific peripheral interventions prez Jeff Mirviss said in a press release.

Earlier this week, a WARN act report emerged showing 85 upcoming layoffs for Boston Scientific at its Burlington, Mass.-based facilities.

Last Chance to Save for DeviceTalks Boston!

Early rates for DeviceTalks Boston end August 15th.

Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.

View Full Agenda

Register today to save. Use code LASTCALL to save an additional 10%.

Calculations & Formulas for Coreless DC Motors
When selecting a Coreless Brush DC Motor for an application, there are several basic motor physics principles to consider to produce a safe, well-functioning, sufficiently-powered precision drive system. In this guide, we’ve provided important methods, formulas & calculations to determine power output of a coreless motor, the speed-torque curve, the current and efficiency plots, and […]
Smithwise helps startup find its focus
After Basil Leaf Technologies won the Qualcomm Tricorder XPrize in 2017, founder Dr. Basil Harris needed help figuring out how to bring this almost-all-in-one diagnostic tool to market. Basil Leaf’s mobile platform DxtER includes a group of non-invasive sensors that can wirelessly communicate with a smart device as they collect data on vital signs, body […]
Webinar: Medical Connector Selection Simplified – August 29
Wednesday, August 29, 2018 11:30am Eastern / 8:30am Pacific What three crucial business questions should you be asking before deciding on a custom connector assembly for your device? What business and technical strategies should you consider before making critical connector decisions? Join us in this live webinar as custom connector industry experts from […]
This implantable mesh can monitor heart activity and apply stimulations
Researchers from the Center for Nanoparticle Research at the Institute for Basic Science have developed a wearable and implantable device that measures electrophysiological signals and stimulates as needed for pain relief, rehabilitation and prosthetic motor control. The soft implantable recorded cardiac activity in multiple points of a swine heart in tests. The researchers on the […]
Avinger posts loss on disappointing sales
Avinger (NSDQ:AVGR) today posted a second-quarter losses-per-share that missed an analyst’s expectation, sending its share price down on Wall Street despite nearly halving its losses. The Redwood City, Calif.-based medical device maker reported losses of -$6.6 million, or -98¢ per share, on sales of $2.1 million for the three months ended June 30, 2018. That compares with […]
BARDA, J&J launch ‘reimagined’ emergency respiratory device challenge
The Dept. of Health and Human Services’ Biomedical Advanced Research and Development Authority and Johnson & Johnson‘s (NYSE:JNJ) Janssen R&D are launching a new crowdsourced tech development challenge looking to support innovative respiratory protection devices, according to a recently listed government posting. The new contest, dubbed the QuickFire Challenge, will look to award up to […]
“Snake oil” BP app got high user marks despite inaccurate results
People may like mobile blood pressure apps better when the apps reveal positive results, even if those results are inaccurate 80% of the time, according to a recent study. A team of researchers who previously revealed the inaccuracy of the Instant Blood Pressure (IBP) app returned to the topic to study 81 adults who compared the […]
Study slams FDA’s ‘fast-track’ approval process
More than 98% of the 161 foot and ankle devices that were recalled from 2007 through 2017 were approved through the FDA’s 510(k) process, according to a new study. That left one recalled device approved via the more stringent premarket approval (PMA) process and two for which the submission procedure was not indicated. The 510(k) process […]
SpaceLabs’ Arkon anesthesia system recalled again
The FDA has slapped SpaceLabs Healthcare with a Class 1 recall of its Arkon anesthesia delivery system for going into a “failed state” on numerous occasions since 2013. The recall covers 253 units. No injuries or deaths were reported. During the failed state, the mechanical ventilation function stops working while the machine is in use […]
Creating water-insoluble APIs using nanomilling
Robert Lee, president, Particle Sciences; Nick DiFranco, marketing specialist, Particle Sciences Poor water solubility is an increasingly common issue in pharmaceutical development. About 40% of marketed drugs and as many as 90% of active pharmaceutical ingredients (APIs) in the discovery pipeline are poorly water-soluble. When these APIs are introduced without modification or enhancement, they fail […]
How sensors could help doctors determine effective cancer treatment options
Chemical engineers from Massachusetts Institute of Technology have developed a sensor that could help doctors determine what the best cancer treatment option is based on how cells react to different types of chemotherapy drugs. The sensors are designed to detect hydrogen peroxide in human cells, which could help researchers determine new cancer drugs that increase […]